BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 32616439)

  • 1. Regulatory mechanisms of RIPK1 in cell death and inflammation.
    Liu Z; Chan FK
    Semin Cell Dev Biol; 2021 Jan; 109():70-75. PubMed ID: 32616439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell Death and Inflammation - A Vital but Dangerous Liaison.
    Peltzer N; Walczak H
    Trends Immunol; 2019 May; 40(5):387-402. PubMed ID: 31003931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High glucose-induced apoptosis and necroptosis in podocytes is regulated by UCHL1 via RIPK1/RIPK3 pathway.
    Xu Y; Gao H; Hu Y; Fang Y; Qi C; Huang J; Cai X; Wu H; Ding X; Zhang Z
    Exp Cell Res; 2019 Sep; 382(2):111463. PubMed ID: 31247189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RIPK1 and RIPK3: critical regulators of inflammation and cell death.
    Newton K
    Trends Cell Biol; 2015 Jun; 25(6):347-53. PubMed ID: 25662614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diverse role of RIP kinases in necroptosis and inflammation.
    Silke J; Rickard JA; Gerlic M
    Nat Immunol; 2015 Jul; 16(7):689-97. PubMed ID: 26086143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interplay of IKK, NF-κB and RIPK1 signaling in the regulation of cell death, tissue homeostasis and inflammation.
    Kondylis V; Kumari S; Vlantis K; Pasparakis M
    Immunol Rev; 2017 May; 277(1):113-127. PubMed ID: 28462531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis.
    Dannappel M; Vlantis K; Kumari S; Polykratis A; Kim C; Wachsmuth L; Eftychi C; Lin J; Corona T; Hermance N; Zelic M; Kirsch P; Basic M; Bleich A; Kelliher M; Pasparakis M
    Nature; 2014 Sep; 513(7516):90-4. PubMed ID: 25132550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Inflammatory Signal Adaptor RIPK3: Functions Beyond Necroptosis.
    Moriwaki K; Chan FK
    Int Rev Cell Mol Biol; 2017; 328():253-275. PubMed ID: 28069136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting RIP Kinases in Chronic Inflammatory Disease.
    Speir M; Djajawi TM; Conos SA; Tye H; Lawlor KE
    Biomolecules; 2021 Apr; 11(5):. PubMed ID: 33924766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caspase-8, receptor-interacting protein kinase 1 (RIPK1), and RIPK3 regulate retinoic acid-induced cell differentiation and necroptosis.
    Someda M; Kuroki S; Miyachi H; Tachibana M; Yonehara S
    Cell Death Differ; 2020 May; 27(5):1539-1553. PubMed ID: 31659279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crucial Roles of the RIP Homotypic Interaction Motifs of RIPK3 in RIPK1-Dependent Cell Death and Lymphoproliferative Disease.
    Zhang H; Wu X; Li X; Li M; Li F; Wang L; Zhang X; Zhang Y; Luo Y; Wang H; Jiang Y; Zhang H
    Cell Rep; 2020 May; 31(7):107650. PubMed ID: 32433959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RIPK1 Kinase-Dependent Death: A Symphony of Phosphorylation Events.
    Delanghe T; Dondelinger Y; Bertrand MJM
    Trends Cell Biol; 2020 Mar; 30(3):189-200. PubMed ID: 31959328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neurotoxicant PCB-95 by increasing the neuronal transcriptional repressor REST down-regulates caspase-8 and increases Ripk1, Ripk3 and MLKL expression determining necroptotic neuronal death.
    Guida N; Laudati G; Serani A; Mascolo L; Molinaro P; Montuori P; Di Renzo G; Canzoniero LMT; Formisano L
    Biochem Pharmacol; 2017 Oct; 142():229-241. PubMed ID: 28676433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging Roles for RIPK1 and RIPK3 in Pathogen-Induced Cell Death and Host Immunity.
    Saleh D; Degterev A
    Curr Top Microbiol Immunol; 2017; 403():37-75. PubMed ID: 26385769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 25 years of research put RIPK1 in the clinic.
    Liu L; Lalaoui N
    Semin Cell Dev Biol; 2021 Jan; 109():86-95. PubMed ID: 32938551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitination of RIPK1 regulates its activation mediated by TNFR1 and TLRs signaling in distinct manners.
    Li X; Zhang M; Huang X; Liang W; Li G; Lu X; Li Y; Pan H; Shi L; Zhu H; Qian L; Shan B; Yuan J
    Nat Commun; 2020 Dec; 11(1):6364. PubMed ID: 33311474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RIP1 post-translational modifications.
    Varfolomeev E; Vucic D
    Biochem J; 2022 May; 479(9):929-951. PubMed ID: 35522161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral Suppression of RIPK1-Mediated Signaling.
    Udawatte DJ; Rothman AL
    mBio; 2021 Aug; 12(4):e0172321. PubMed ID: 34372694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. K45A mutation of RIPK1 results in poor necroptosis and cytokine signaling in macrophages, which impacts inflammatory responses in vivo.
    Shutinoski B; Alturki NA; Rijal D; Bertin J; Gough PJ; Schlossmacher MG; Sad S
    Cell Death Differ; 2016 Oct; 23(10):1628-37. PubMed ID: 27258786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors Targeting RIPK1/RIPK3: Old and New Drugs.
    Martens S; Hofmans S; Declercq W; Augustyns K; Vandenabeele P
    Trends Pharmacol Sci; 2020 Mar; 41(3):209-224. PubMed ID: 32035657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.